Skip to main content

Table 3 Cox proportional hazard regression

From: Multimorbidity and long-term care dependency—a five-year follow-up

 

Model 1

Model 2

Model 3

Model 4

 

HR

   CI

HR

   CI

HR

   CI

HR

   CI

Multimorbidity

1.41

1.36

1.47

      

1.16

1.12

1.21

Sex

0.37

0.25

0.54

0.51

0.35

0.75

0.43

0.3

0.62

0.47

0.32

0.68

Age

1.14

1.13

1.15

1.13

1.12

1.14

1.14

1.13

1.15

1.14

1.13

1.15

Interaction age/sex

1.01

1.01

1.02

1.01

1.00

1.01

1.01

1.01

1.02

1.01

1.01

1.02

Cluster: CMD*

      

1.11

1.07

1.15

   

Cluster: ADSP*

      

1.25

1.21

1.30

   

Cluster: NPS*

      

1.79

1.63

1.97

   

Parkinson’s disease

   

2.86

2.59

3.15

   

3.04

2.76

3.35

Dementia

   

2.37

2.18

2.57

   

2.49

2.29

2.70

Tobacco abuse

   

1.69

1.46

1.96

   

1.86

1.60

2.15

Cerebral ischemia/chronic stroke

   

1.53

1.44

1.63

   

1.53

1.44

1.63

Diabetes mellitus

   

1.48

1.42

1.54

   

1.51

1.46

1.57

Urinary incontinence

   

1.39

1.27

1.52

      

Cancer

   

1.36

1.30

1.42

      

Cardiac insufficiency

   

1.32

1.26

1.40

      

Asthma/COPD

   

1.32

1.26

1.39

      

Anemia

   

1.30

1.19

1.43

      

Depression

   

1.28

1.21

1.35

      

Renal insufficiency

   

1.26

1.17

1.36

      

Atherosclerosis/PAOD

   

1.22

1.15

1.28

      

Rheumatoid arthritis/chronic polyarthritis

   

1.21

1.09

1.33

      

Neuropathies

   

1.17

1.10

1.25

      

Dizziness

   

1.15

1.06

1.24

      

Liver disease

   

1.12

1.06

1.20

      

Obesity

   

1.11

1.04

1.18

      

Chronic ischemic heart disease

   

1.08

1.04

1.13

      

Osteoporosis

   

1.08

1.02

1.15

      

Joint arthrosis

   

1.08

1.03

1.13

      

Insomnia

   

1.07

0.99

1.15

      

Cardiac arrhythmias

   

1.06

1.01

1.12

      

Cardiac valve disorders

   

1.06

0.97

1.15

      

Hyperuricemia/gout

   

1.04

0.99

1.10

      

Hypertension

   

1.02

0.98

1.05

      

Hypotension

   

1.02

0.87

1.18

      

Anxiety

   

1.01

0.88

1.16

      

Chronic cholecystitis/gallstones

   

1.00

0.93

1.07

      

Psoriasis

   

1.00

0.88

1.13

      

Severe hearing loss

   

0.97

0.89

1.06

      

Lower limb varicosis

   

0.96

0.91

1.01

      

Chronic gastritis/GERD

  

0.96

0.90

1.01

      

Allergy

   

0.93

0.85

1.02

      

Severe vision reduction

   

0.92

0.88

0.96

      

Chronic low back pain

   

0.90

0.87

0.94

      

Migraine/chronic headache

   

0.90

0.78

1.03

      

Intestinal diverticulosis

   

0.88

0.8

0.97

      

Thyroid diseases

   

0.87

0.82

0.91

      

Somatoform disorders

   

0.86

0.79

0.95

      

Prostatic hyperplasia

   

0.84

0.79

0.89

      

Urinary tract calculi

   

0.81

0.72

0.91

      

Hemorrhoids

   

0.80

0.73

0.88

      

Lipid metabolism disorders

   

0.79

0.76

0.82

      

Sexual dysfunction

   

0.78

0.66

0.93

      

Gynecological problems

   

0.75

0.68

0.83

      
  1. *Clusters: CMD: cardiovascular and metabolic disorders; ADS/P: anxiety, depression, somatoform disorders, and pain; NPS: neuropsychiatric disorders; see [28] for details.